Abstract
Objective: To investigate the relationship between inflammatory [interleukin-6 (IL-6) and C-reactive protein (CRP)] and coagulation (D-dimer) biomarkers and cancer risk during HIV infection. Design: A prospective cohort. Methods: HIV-infected patients on continuous antiretroviral therapy (ART) in the control arms of three randomized trials (N = 5023) were included in an analysis of predictors of cancer (any type, infection-related or infection-unrelated). Hazard ratios for IL-6, CRP and D-dimer levels (log2-transformed) were calculated using Cox models stratified by trial and adjusted for demographics and CD4+ cell counts and adjusted also for all biomarkers simultaneously. To assess the possibility that biomarker levels were elevated at entry due to undiagnosed cancer, analyses were repeated excluding early cancer events (i.e. diagnosed during first 2 years of follow-up). Results: During approximately 24 000 person-years of follow-up (PYFU), 172 patients developed cancer (70 infection-related; 102 infection-unrelated). The risk of developing cancer was associated with higher levels (per doubling) of IL-6 (hazard ratio 1.38, P
Original language | English |
---|---|
Pages (from-to) | 1433-1441 |
Number of pages | 9 |
Journal | AIDS (London, England) |
Volume | 27 |
Issue number | 9 |
DOIs | |
Publication status | Published - Jun 1 2013 |
Keywords
- Biomarkers
- C-reactive protein
- Cancer
- D-dimer
- HIV
- Interleukin-6
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases